Breathe Well Live Well
|
Theravance Reports Third Quarter 2010 Financial Results
MarketWatch (press release) "The RELOVAIR(TM) Phase 3 programs in COPD and asthma are progressing well and have now enrolled over 8000 patients. Last month, preclinical and Phase 2a … |
View full post on asthma – Google News
|
Clinical Data Reports Positive Results From Early-stage Trials Of Stedivaze In …
RTT News Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings support the potential … |
View full post on asthma – Google News
 Proactive Investors USA & Canada |
GlaxoSmithKline, Theravance Combined Drug for COPD Shows Postitive Results
FOXBusiness … Wednesday that their combined treatment for patients with chronic obstructive pulmonary disorder and asthma posted strong results in a clinical study. … Glaxo, Theravance report Relovair safety data GSK and Theravance announce combination ICS/LABA Phase II results in the … GlaxoSmithKline and Theravance announce positive phase II results for Relovair … |
View full post on asthma – Google News
|
GSK and Theravance announce combination ICS/LABA Phase II results in the …
MarketWatch (press release) Our ongoing collaboration with GSK includes the Phase III programmes in both COPD and asthma, which are already underway for Relovair and its components. … Theravance Announces Results From Phase II Study For Developmental Combination … |
View full post on asthma – Google News
|
New Combination for Asthma Shows Encouraging Results in Delivering Efficacy …
PR Newswire UK (press release) The FP/FORM combination has also been shown to be more effective in controlling asthma symptoms than FP alone(2). Despite a range of available therapies, … |
View full post on asthma – Google News
|
MediciNova Reports Second Quarter 2010 Results
MarketWatch (press release) MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, COPD exacerbations, multiple sclerosis and … |
View full post on asthma – Google News
|
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA …
PR Newswire (press release) While AR itself is not life-threatening (unless accompanied by severe asthma or anaphylaxis), morbidity associated with the condition can be significant. … |
View full post on asthma – Google News
Today we congratulate the Centre for the AIDS Programme of Research in South Africa (CAPRISA) and the people of South Africa on the positive findings from the CAPRISA 004 microbicide study, which marks a significant milestone both for the microbicide research field and HIV prevention as a whole.
View full post on National Institutes of Health (NIH) News Releases